Mylan may have overcharged U.S. for EpiPens by $1.27 billion: HHS

File photo: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.  REUTERS/Jim Bourg/File Photo
File photo: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.

REUTERS/Jim Bourg/File Photo

Visit the Source Site

Powered by WPeMatico